Discover Helus Pharma stock analysis as it closes at $8.87 with a 0.11% gain, holding above 200-session EMA with bearish daily bias.
Helus Pharma stock carries a bearish daily bias into the next session, despite holding above its 200-session exponential moving average. The hourly chart supports that cautious reading. A positive 15-minute MACD histogram offers a limited counterpoint, but does not outweigh the broader price structure.
Summary
Key takeaways
- HELP closed at $8.87 on Friday, November 13, 2026, with a gain of 0.11%.
- The close sits below the daily 20-session EMA ($9.69) and 50-session EMA ($10.35) but above the 200-session EMA ($8.81).
- Daily RSI14 is 39.16, below 50; daily MACD histogram is -0.01.
- Hourly RSI14 is 43.7, and the close sits below all three hourly EMAs.
- Next-session daily pivot is $8.81, with first resistance at $9.12 and first support at $8.56.
In Friday’s session, November 13, 2026, HELP opened at $8.91, traded between a low of $8.50 and a high of $9.06, and closed at $8.87, against a previous close of $8.86. That was a gain of 0.11% versus the previous close.
Meanwhile, a report published on Sunday, November 15, said Helus Pharma was scheduled to present Phase 3 depression trial results on Monday, November 16. The report appeared on a later day than Friday’s session and cannot explain that session’s move. It establishes a scheduled presentation, not the trial’s outcome.
Helus Pharma stock faces daily resistance above support
On the daily timeframe, the close sits below the 20-session EMA at $9.69 and the 50-session EMA at $10.35. Those averages define overhead resistance. However, the close remains above the 200-session EMA at $8.81, so the daily averages do not form a fully bearish alignment.
Daily RSI14 stands at 39.16, below 50 but above oversold territory. At the same time, the MACD line is -0.63, below its signal at -0.61, with a negative histogram of -0.01. Together, these readings support the bearish bias without an oversold RSI condition.
Moreover, the close sits below the daily Bollinger mid-band at $9.78, between the lower band at $8.03 and upper band at $11.53. That places price in the lower half of the band structure. Daily ATR14 reads $0.83, providing a volatility reference rather than a directional signal.
When trading resumes, the daily pivot for the next session sits at $8.81. Daily first resistance is $9.12, and daily first support is $8.56. Notably, these levels are calculated from the completed daily candle and frame the next session, not Friday’s trading.
Hourly confirmation, with a short-term conflict
Meanwhile, HELP’s $8.87 close sits below the hourly 20-hour EMA at $8.99, the 50-hour EMA at $9.14, and the 200-hour EMA at $10.23. As a result, price and those averages are bearishly aligned. Hourly RSI14 is 43.7, below 50. Additionally, the hourly MACD line of -0.09 is below its signal of -0.07, reinforcing the daily caution.
In contrast, the 15-minute MACD line is 0, above its signal at -0.01, with a positive histogram of 0.01. That is a short-term counterweight, not confirmation of a bullish daily setup. Still, the 15-minute RSI14 remains below 50 at 46.94.
For execution context, the close equals the 15-minute Bollinger mid-band at $8.87. It remains below the 20-period EMA at $8.89, the 50-period EMA at $8.96, and the 200-period EMA at $9.16. The positive MACD histogram therefore conflicts with bearish average alignment on this timeframe.
Bullish and bearish conditions for the next session
For the next session, a bullish case requires holding the daily 200-session EMA and next-session daily pivot, both at $8.81. Initially, clearing the hourly 20-hour EMA at $8.99 would address the first overhead average. A sustained move above next-session daily first resistance at $9.12 would strengthen that case. The daily 20-session EMA at $9.69 would then be the next broader reference.
Conversely, a break below $8.81 would undermine that bullish case. Next-session daily first support at $8.56 would then become the immediate reference, followed by Friday’s low at $8.50. In that scenario, a break below both would leave the daily lower Bollinger band at $8.03 as the lower chart reference.
Overall, Helus Pharma stock stands above $8.81 support but below its hourly and daily overhead averages. Daily ATR14 of $0.83 frames the volatility. The unresolved questions are whether support holds and what the planned trial-results presentation contains.
FAQ
Where does HELP stand relative to its daily moving averages?
HELP’s close at $8.87 sits below the 20-session EMA ($9.69) and the 50-session EMA ($10.35), but remains above the 200-session EMA ($8.81). The averages do not form a fully bearish alignment.
What levels should traders watch in the next session?
The daily pivot for the next session is $8.81, with first resistance at $9.12 and first support at $8.56. The 200-session EMA also sits at $8.81, reinforcing that level. Friday’s low at $8.50 and the daily lower Bollinger band at $8.03 are additional references below.
What does the hourly chart indicate for HELP?
The hourly chart shows the close below all three hourly EMAs — the 20-hour at $8.99, the 50-hour at $9.14, and the 200-hour at $10.23. Hourly RSI14 is 43.7, below 50, and the hourly MACD line is below its signal, reinforcing the bearish bias.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Read also: NeuroPace stock falls 47.3%, from $12.02 to $6.33 as of 14:19 ET
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.



